India has signed the much-awaited first purchase agreement for the government-sponsored Covid vaccination programme with Pune-based Serum Institute of India. Talks were on with Hyderabad-headquartered Bharat Biotech till the time of going to press. The nationwide vaccination drive is starting on January 16.
According to sources, Serum Institute, which is manufacturing the AstraZeneca-Oxford vaccine, is likely to supply around 11 million doses of Covishield in the first lot to the Centre for Rs 200 per dose. Pricing for Covaxin from Bharat Biotech is being negotiated, a person close to the development said. The companies declined to comment on the matter.
The first